Hawkins, Inc. (NASDAQ:HWKN) Shares Purchased by NorthRock Partners LLC

NorthRock Partners LLC grew its holdings in shares of Hawkins, Inc. (NASDAQ:HWKNFree Report) by 54.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,031 shares of the specialty chemicals company’s stock after purchasing an additional 9,913 shares during the period. NorthRock Partners LLC owned approximately 0.13% of Hawkins worth $3,435,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Wasatch Advisors LP bought a new stake in Hawkins during the fourth quarter worth approximately $42,466,000. Vaughan Nelson Investment Management L.P. boosted its stake in shares of Hawkins by 487.7% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 254,837 shares of the specialty chemicals company’s stock worth $31,260,000 after acquiring an additional 211,472 shares in the last quarter. Northern Trust Corp grew its holdings in shares of Hawkins by 16.1% in the 4th quarter. Northern Trust Corp now owns 235,096 shares of the specialty chemicals company’s stock worth $28,839,000 after acquiring an additional 32,670 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Hawkins by 61.9% during the fourth quarter. JPMorgan Chase & Co. now owns 149,616 shares of the specialty chemicals company’s stock worth $18,353,000 after purchasing an additional 57,179 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in shares of Hawkins during the fourth quarter worth $13,087,000. Institutional investors and hedge funds own 69.71% of the company’s stock.

Analyst Ratings Changes

HWKN has been the subject of a number of analyst reports. CJS Securities assumed coverage on shares of Hawkins in a research note on Tuesday, April 1st. They set a “market outperform” rating and a $125.00 price objective for the company. BWS Financial raised Hawkins from a “neutral” rating to a “buy” rating and set a $160.00 target price for the company in a research report on Monday, April 14th.

Check Out Our Latest Analysis on HWKN

Hawkins Price Performance

Shares of HWKN opened at $120.29 on Wednesday. The business’s 50-day moving average is $113.42 and its 200-day moving average is $117.00. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.50 and a quick ratio of 1.53. The company has a market capitalization of $2.52 billion, a price-to-earnings ratio of 30.69, a P/E/G ratio of 3.80 and a beta of 0.87. Hawkins, Inc. has a fifty-two week low of $71.98 and a fifty-two week high of $139.55.

Hawkins Profile

(Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Further Reading

Institutional Ownership by Quarter for Hawkins (NASDAQ:HWKN)

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.